Normal tissue effects: Reporting and analysis

Seminars in Radiation Oncology

Volumn 13, Issue 3, 2003, Pages 189-202

  Bentzen, Soren M ^a   Dörr, Wolfgang ^b   Anscher, Mitchell S ^b   Denham, James W ^b   Hauer Jensen, Martin ^b   Marks, Lawrence B ^b   Williams, Jacqueline ^b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ACUTE TOXICITY; CANCER RADIOTHERAPY; CHRONIC TOXICITY; CLINICAL RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; COUGHING; DISEASE SEVERITY; DYSPNEA; HUMAN; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG SCINTISCANNING; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PAIN; PREDICTION; PRIORITY JOURNAL; RADIATION INJURY; RATING SCALE; TISSUE INJURY; TOXICITY TESTING;

EID: 0042528619     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-4296(03)00036-5     Document Type: Conference Paper

References (41)

1. Dorr W, Hendry JH: Consequential late effects in normal tissues. Radiother Oncol 61:223-231, 2001
2. Denham JW, Hauer-Jensen M, Peters LJ: Is it time for a new formalism to categorize normal tissue radiation injury? Int J Radiat Oncol Biol Phys 50:1105-1106, 2001
3. Bentzen SM, Overgaard J: Clinical manifestations of normal-tissue damage, in Steel GG (ed): Basic Clinical Radiobiology. London, Arnold, 1997, pp 87-97
4. Trotti A, Byhardt R, Stetz J: Common toxicity criteria: version 2.0: An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 47:13-47, 2000
5. Maciejewski B, Zajusz A, Pilecki B: Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer. Radiother Oncol 22:7-11, 1991
6. Dische S, Warburton MF, Jones D: The recording of morbidity related to radiotherapy. Radiother Oncol 16:103-108, 1989
7. Pavy J-J, Denekamp J, Letschert J: Late effects damage scoring: The SOMA scale. Radiother Oncol 35:11-60, 1995
8. Rubin P, Constine LS, Fajardo LF: Overview: Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31:1041-1042, 1995
9. Yeoh E, Horowitz M, Russo A: Effect of pelvic irradiation on gastrointestinal function: A prospective longitudinal study. Am J Med 95:397-406, 1993
10. Marks LB, Carroll PR, Dugan TC: The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31:1257-1280, 1995
11. Taylor JMG: Properties of maximum likelihood estimates of the ratio of parameters in ordinal response regression models. Commun Statist-Simula 19:469-480, 1990
12. Bentzen SM, Thames HD, Travis EL: Direct estimation of latent time for radiation injury in late-responding normal tissues: Gut, lung and spinal cord. Int J Radiat Biol 55:27-43, 1989
13. Bentzen SM, Saunders MI, Dische S: Radiotherapy-related early morbidity in head and neck cancer: Quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 60:123-135, 2001
14. Lajer H, Thranov IR, Bagi P: Evaluation of urologic morbidity after radiotherapy for cervical carcinoma by urodynamic examinations and patient voiding schemes: A prospective study. Int J Radiat Oncol Biol Phys 54:1362-1368, 2002
15. Bentzen SM: Dose-response relationships in radiotherapy, in Steel GG (ed): Basic Clinical Radiobiology. London, Arnold, 2002, pp 94-104
16. Denekamp J, Bartelink H, Rubin P: Correction for the use of the SOMA LENT tables. Radiother Oncol 39:191-191, 1996
17. Denekamp J, Bartelink H, Rubin P: Correction for the use of the SOMA LENT tables. Int J Radiat Oncol Biol Phys 35:417, 1996
18. Anacak Y, Yalman D, Ozsaran Z: Late radiation effects to the rectum and bladder in gynecologic cancer patients: The comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems. Int J Radiat Oncol Biol Phys 50:1107-1112, 2001
19. Livsey JE, Routledge J, Burns M: Scoring of treatment-related late effects in prostate cancer. Radiother Oncol 65:109-121, 2002
20. Bentzen SM, Turesson I, Thames HD: Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: A graded response analysis. Radiother Oncol 18:95-106, 1990
21. Turesson I: Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 19:1569-1574, 1990
22. Hatlevoll R, Host H, Kaalhus O: Myelopathy following radiotherapy of bronchial carcinoma with large single fractions: A retrospective study. Int J Radiat Oncol Biol Phys 9:41-44, 1983
23. Abratt RP: Reporting the late complication rates of cancer therapy. Br J Radiol 56:348-350, 1983
24. Caplan RJ, Pajak TF, Cox JD: Analysis of the probability and risk of cause-specific failure. Int J Radiat Oncol Biol Phys 29:1183-1186, 1994
25. Bentzen SM, Vaeth M, Pedersen D: Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment...NOW. Int. J Radiat Oncol Biol Phys 32:1531-1534, 1995
26. Haie-Meder C, Kramar A, Lambin P: Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys 29:953-960, 1994
27. Johansson S, Svensson H, Denekamp J: Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 48:745-750, 2000
28. Lundby L, Jensen VJ, Overgaard J: Long-term colorectal function after postoperative radiotherapy for colorectal cancer. Lancet 350:564, 1997
29. Eifel PJ, Levenback C, Wharton JT: Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32:1289-1300, 1995
30. Jung H, Beck-Bornholdt HP, Svoboda V: Quantification of late complications after radiation therapy. Radiother Oncol 61:233-246, 2001
31. Bentzen SM, Dische S: Late morbidity: The Damocles sword of radiotherapy? Radiother Oncol 61:219-221, 2001
32. Anscher MS, Kong FM, Andrews K: Plasma transforming growth factor betal as a predictor of radiation pneumonitis. Int. J Radiat Oncol Biol Phys 41:1029-1035, 1998
33. Anscher MS, Marks LB, Shafman TD: Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol 19:3758-3765, 2001
34. Hovdenak N, Fajardo LF, Hauer-Jensen M: Acute radiation proctitis: A sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 48:1111-1117, 2000
35. Rubin P, Johnston CJ, Williams JP: A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33:99-109, 1995
36. Denham JW, Hauer-Jensen M: The radiotherapeutic injury - A complex 'wound'. Radiother Oncol 63:129-145, 2002
37. Barcellos-Hoff MH: How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat Res 150:S109-S120, 1998
38. Barcellos-Hoff MH: Radiation-induced transforming growth factor a and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 53:3880-3886, 1993
39. Fantuzzi G: Lessons from interleukin-deficient mice: The interleukin-I system. Acta Physiol Scand 173:5-9, 2001
40. Safwat A, Bentzen SM, Turesson I: Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int. J Radiat Oncol Biol Phys 52:198-204, 2002
41. Hanlon AL, Schultheiss TE, Hunt MA: Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys 38:59-63, 1997